Comparative Antianaerobic Activity of BMS 284756

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.45.2.589-592.2001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Garenoxacin (BMS-284756) and Moxifloxacin in Experimental Meningitis Caused by Vancomycin-Tolerant Pneumococci

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2003English

Efficacies of BMS 284756 Against Penicillin-Sensitive, Penicillin-Resistant, and Quinolone-Resistant Pneumococci in Experimental Meningitis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2002English

Evaluation of T-3811me (BMS-284756), a New Des-F(6)-Quinolone, for Treatment of Meningitis Caused by Penicillin-Resistant Streptococcus Pneumoniae in Rabbits

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2002English

In Vitro Activities of Novel Des-Fluoro(6) Quinolone BMS-284756 Against Mutants of Streptococcus Pneumoniae, Streptococcus Pyogenes, and Staphylococcus Aureus Selected With Different Quinolones

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2002English

In Vitro Activity of BMS-181139, a New Carbapenem With Potent Antipseudomonal Activity

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1995English

In Vitro Activity of a New Oral Triazole, BMS-207147 (ER-30346)

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1998English

Tower of Subleading Dual BMS Charges

Journal of High Energy Physics
High Energy PhysicsNuclear
2019English

The Conformal BMS Group

Journal of High Energy Physics
High Energy PhysicsNuclear
2017English

BMS Characters and Modular Invariance

Journal of High Energy Physics
High Energy PhysicsNuclear
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy